Literature DB >> 32078839

Fine particulate matter aggravates intestinal and brain injury and affects bacterial community structure of intestine and feces in Alzheimer's disease transgenic mice.

Pengfei Fu1, Lirong Bai2, Zongwei Cai3, Ruijin Li4, Ken Kin Lam Yung5.   

Abstract

Fine particulate matter (PM2.5) was a risk factor for neurological disorders when emerging studies revealed that PM2.5 affected the bacterial community structure of gut in Alzheimer's disease (AD) patients. The purpose of this study was to explore the effects of PM2.5 on intestinal and brain injury and on bacterial community structure in the intestine and feces of APP/PS1 transgenic mice exposed to PM2.5 for eight weeks with a real-world whole-body inhalation exposure system in Taiyuan, China. The brain and intestinal tissues were collected to evaluate histopathological changes by HE staining. TNF-α and IL-6 levels in intestines, brains, and serums, and Aβ-42 levels in brains were detected. Intestinal and fecal samples were subjected to 16S rRNA gene sequencing. Results showed that PM2.5 significantly aggravated the pathological injury in intestines and brains in AD mice with elevated pro-inflammatory cytokine levels. The estimators of Shannon, Simpson, Chao1, and ACE indexes reflected the diversity and richness of the bacterial community. Compared with the FA-WT group, the FA-AD group had lower diversity and richness when the PM2.5-AD group had the highest ones. PCA and NMDS revealed the specific influence of PM2.5 on the bacterial community of intestine and feces because that the PM2.5-FA and PM2.5-AD group clumped visibly closer than the other groups in both bacterial communities of intestine and feces. The KEGG pathway analysis predicted the vital functional genes and metabolic pathways in the bacterial community of PM2.5-AD mice. This study indicated the histopathological changes and inflammation in the intestine and brain were seriously caused in PM2.5-AD mice when the α-diversity of the bacterial community in intestine and feces was visibly changed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease transgenic mice; Bacterial community; Brain; Feces; Fine particulate matter; Intestine

Year:  2020        PMID: 32078839     DOI: 10.1016/j.ecoenv.2020.110325

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  5 in total

Review 1.  Particulate matter and Alzheimer's disease: an intimate connection.

Authors:  Devin R O'Piela; George R Durisek; Yael-Natalie H Escobar; Amy R Mackos; Loren E Wold
Journal:  Trends Mol Med       Date:  2022-07-12       Impact factor: 15.272

Review 2.  Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review.

Authors:  Ricardo G Suarez; Alvaro R Osornio-Vargas; Eytan Wine
Journal:  Dig Dis Sci       Date:  2022-06-25       Impact factor: 3.487

3.  NeuroSmog: Determining the Impact of Air Pollution on the Developing Brain: Project Protocol.

Authors:  Iana Markevych; Natasza Orlov; James Grellier; Katarzyna Kaczmarek-Majer; Małgorzata Lipowska; Katarzyna Sitnik-Warchulska; Yarema Mysak; Clemens Baumbach; Maja Wierzba-Łukaszyk; Munawar Hussain Soomro; Mikołaj Compa; Bernadetta Izydorczyk; Krzysztof Skotak; Anna Degórska; Jakub Bratkowski; Bartosz Kossowski; Aleksandra Domagalik; Marcin Szwed
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

4.  Etiology Analysis and Diagnosis and Treatment Strategy of Traumatic Brain Injury Complicated With Hyponatremia.

Authors:  Jianhua Zhang; Wensheng Dong; Xianghong Dou; Jinjin Wang; Peng Yin; Hui Shi
Journal:  Front Surg       Date:  2022-02-21

5.  Long-term effects of PM2.5 components on incident dementia in the northeastern United States.

Authors:  Jing Li; Yifan Wang; Kyle Steenland; Pengfei Liu; Aaron van Donkelaar; Randall V Martin; Howard H Chang; W Michael Caudle; Joel Schwartz; Petros Koutrakis; Liuhua Shi
Journal:  Innovation (Camb)       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.